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Abstract This paper reports the purification of four peptides 
related to enkephalins from the brain of the leech Theromyzon 
tessulatum. After reverse-phase HPLC purification, the sequence 
of the enkephalins (YGGFM, YGGFL, FM, FL) was established 
by a combination of automated Edman degradation, electrospray 
mass spectrometry measurement, and co-elution experiments in 
reverse-phase HPLC with synthetic peptides. ELISA titrations 
performed on each purified peptide indicated that the major 
amount was borne by the leucine-enkephalin. The ratio of leucine- 
enkephalin and methionine-enkephalin of 2:1 is in line with previ- 
ous immunocytochemical data obtained on T. tessulatum brains. 
The presence of enkephalins in T. tessulatum, an animal belong- 
ing to the oldest group of coelomate metazoans (the Annelida) 
establishes the very ancient phylogenetic origin of opioids and 
their conservation in the course of evolution. 
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I. Introduction 
Since their discovery in mammalian brain by Hughes et al. 
[1], opioids have been presumed to be specific to vertebrates. 
However, by means of radioimmunoassay nd immunocyto- 
chemistry, evidence of enkephalin-like substances in all phyla 
of invertebrates has been demonstrated [2 6]. Finally in 1984, 
enkephalins (methionine-enkephalin (Met-enk), leucine- 
enkephalin (Leu-enk)) and the heptapeptide [Met-enk-Arg 6- 
Phe7], were isolated from the pedal ganglia of the mollusc 
Mytilus edulis [7]. Recently, in crustacea, by a combined ap- 
proach of mass spectrometry and amino acid sequence analysis, 
a Leu-enk and a Met-enk has been characterized from thoracic 
ganglia of the shore crab Carcinus maenas L. [8]. 
In leeches, enkephalin-like immunoreactivities were found 
in two species, the gnatobdellid Hirudo medicinalis [9-13] and 
the rhynchobdellid Theromyzon tessulatum [14~16]. These 
*Corresponding author. Fax: (33) 20 43 68 49. 
Abbreviations." a-Leu-enk, anti-leucine-enkephalin; a-Met-enk, anti- 
methionine-enkephalin; DIA, dot immunobinding assay; ELISA 
enzyme-linked immunosorbent assays; ESMS, electrospray mass spec- 
trometry; HPLC, high performance liquid chromatography; HPGPC, 
high performance gel permeation chromatography; Leu-enk, leucine- 
enkephalin; y-MSH, ),-melanocyte stimulating hormone; Met-enk, 
methionine-enkephalin; POMC, pro-opiomelanocortin; Proenk, pro- 
enkephalin; Prodyn, prodynorphin; RT, retention time; TFA, tri- 
fluoroacetic acid. 
immunoreactivities were detected in brain [15,16], the ventral 
nerve cord [9-14] and the peripheral nervous system [13,14]. 
Since these previous studies in immunocytochemistry, no fur- 
ther peptides related to the opioid family have been isolated in 
leeches. 
We now report the isolation and the characterization of 
enkephalins in leeches, animals belonging to the oldest group 
of coelomate metazoans (the Annelida). 
2. Materials and methods 
2.1. Animals 
Mature specimens of the rhynchobdellid leech T. tessulatum, reared 
under laboratory conditions as described by Malecha et al. [17], were 
used in this study. 
2.2. Antisera 
Polyclonal antisera anti-methionine-enkephalin (a-Met-enk) and 
anti-leucine-enkephalin (a-Leu-enk) raised in rabbits, kindly provided 
by Dr G. Tramu (Laboratoire de Neurocytochimie fonctionnelle, 
Universit6 de Bordeaux I, Talence, France), were used in immuno- 
binding assays. Their specificities were previously described elsewhere 
[18]. In short, the a-Leu-enk did not cross-react with Met-enk, and the 
a-Met-enk showed a cross-reactivity of 0.4% with Leu-enk. 
2.3. Immunoassays 
Enzyme-linked immunosorbent assays (ELISA) and dot immuno- 
binding assays (DIA) were conducted according to Salzet et al. [19,20] 
with a-Met-enk and a-Leu-enk employed at a dilution of 1 : 1000. As 
a control, preadsorption of anti-enkephalins was carried out using 
homologous peptides. Prior to ELISA and DIA, a-Met-enk or a-Leu- 
enk, at their working dilution, were respectively incubated overnight at 
4°C with Met-enk and with Leu-enk (Sigma) (100/2g of synthetic 
peptide per ml of undiluted antiserum). 
2.4. Purification 
A five-step procedure was employed (Table 1). 
After anaesthesia of the animals in 0.01% chloretone, 1000 brains 
were excised, immediately frozen in liquid nitrogen and stored at -70°C 
until use. Batches of 200 brains were homogenized and extracted with 
200/21 1 M acetic acid at 4°C. After centrifugation at 12,000 rpm for 
30 min at 4°C, the pellet was re-extracted once. The two supernatants 
were combined and loaded onto Sep-Pak C~8 cartridges (500/21 extract/ 
cartridge; Waters). After washing the cartridges with 5 ml 1 M acetic 
acid, elution was performed with 5 ml 50% acetonitrile in acidified 
water (0.1% TFA; Pierce). The 50% eluted fraction was reduced 20-fold 
in a vacuum centrifuge (Savant). The total amount of enkephalin-like 
material was quantified using ELISA. The 50% eluted fraction was 
taken up to 250/21 with acidified water (0.1% TFA) and fractionated 
on a HPGPC column (Ultraspherogel, 7,5 x 300 mm, SEC2000; Beck- 
man). Samples were eluted with 30% acetonitrile in acidified water at 
a flow rate of 500/21/min. Fractions immunoreactive in DIA to either 
a-Met-enk or a-Leu-enk were concentrated before being separated on 
a C18-peptide protein column (250 x 4.6 mm; Vydac) equilibrated with 
acidified water (0.1% TFA). Elution was performed with a discontinu- 
ous linear gradient of acetonitrile in acidified water over 0-15% for 10 
min and over 15-45% for 30 min at a flow rate of I ml/min. The column 
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effluent was monitored by absorbance at 226 nm and the presence of 
enkephalin-like material detected on aliquots of each fraction by DIA. 
The fractions that contained the immunoreactive material were ana- 
lyzed on the same column with a shallower gradient of acetonitrile from 
0-15% in 10 min followed by a gradient of 15-45% in 40 min (increase 
of 0.75%/min instead of 1%/min for the previous tep). After concentra- 
tion by freeze drying, fraction aliquots of 0.5/21 were tested by DIA. 
The enkephalin-like material was finally purified on an ODS C~8 re- 
verse-phase column (Ultrasphere, 250times;2 mm; Beckman) developed 
with a linear gradient of 0-60% acetonitrile inacidified water for 60 rain 
at a flow rate of 50/21/min. The column effluent was monitored by 
absorbance at 226 nm and the immunoreactive material detected as 
above. 
Co-elutions in reverse-phase HPLC were performed with synthetic 
Met-enk and Leu-enk peptides purchased from Sigma. 
All HPLC purifications were performed with a Beckman Gold 
HPLC system equipped with a photo diode array detector Beckman 
168. 
2.5. Peptide oxidation 
50/21 of a solution of 50 pmol of purified peptide were oxidized in 
100/21 of pure H202 for 1 h. Then, the oxidized peptide was separated 
by reverse-phase HPLC. 
2.6. Structure determination 
Automated Edman degradation of each purified peptide and detec- 
tion of phenylthiohydantoin (PTH-Xaa) derivatives were performed on 
a pulse liquid automatic sequentator (Applied Biosystems, model 
473A). 
The molecular mass of each peptides was determined by electrospray 
mass spectrometry (ESMS). The purified peptide was dissolved in 
water/methanol (50/50, v/v) containing 1% acetic acid and analyzed on 
a VG Biotech BioQ mass spectrometer (Manchester). This instrument 
consists of an electrostatic ion-spray source operating at atmospheric 
pressure, followed by a quadrupole mass analyzer with a mass range 
of 1-4000. The extraction cone voltage value was 55 V. Scanning was 
performed from m/z = 500-1500 for 10 s, with the resolution adjusted 
so that the m/z = 998 peak from horse myoglobin was 1.5-1.7 Da wide 
at its base. The data system was operated as a multi-channel analyzer 
and several scans were summed to obtain the final spectrum. Each 
molecular species produced a series of multiply charged protonated 
molecular ions from which the molecular mass was determined by 
simple calculation. Calibration was performed using the multiply 
charged ions from a separate introduction of horse heart myoglobin 
(16,951.4 Da). Molecular masses are given as average values based on 
the atomic weights of the elements (C = 12.011, H = 1.00794, 
N = 14.0067, O = 15.9994 and S = 32.06); only average masses were 
measured. 
3. Results 
3.1. Isolation of enkephalin-like peptides 
1000 brains of T. tessulatum were subjected to peptide xtrac- 
tion in 1 M acetic acid, pH 2. ELISA of crude extract revealed 
ca. 7 pmol of Leu-enk/brain and ca, 4 pmol of Met-enk/brain. 
The crude extract was prepurified using Sep-Pak C~s cartridges. 
The fraction eluted by 50% acetonitrile containing the enkeph- 
alin-like material was reduced 20-fold by freeze-drying and 
applied to a HPGPC column. The eluted fractions obtained 
were tested in DIA and revealed a single immunoreactive zone 
of both a-Met-enk and a-Leu-enk corresponding to peptides 
with molecular masses o f -0 .2  1 kDa (Fig. 1). An amount of 
5.35 + 0.35 pmol of Leu-enk/brain (recovery of ca. 84%) and 
of 3.05 + 0.55 pmol of Met-enk/brain (recovery of ca. 82%) was 
obtained at this step 2 of the purification. Results obtained after 
preadsorption of the antisera by synthetic enkephalins estab- 
lished the specificity of the immunodetection. The immunoreac- 
tive fractions were then concentrated 20-fold and applied to a 
reverse-phase HPLC. 
In the first step of reverse-phase HPLC on a Vydac C18 
column, Met-enk-like substances eluted in several fractions 
with RT ranging from 13-14 min and 21-22 min and Leu-enk- 
like substances between 13-14 min and 23-24 min (Fig. 2). 
Under these conditions vertebrate Met-enk eluted at a Rv of 
21.8 rain and Leu-enk at a RT of 23.3 rain. In the second step 
of reverse-phase HPLC, conducted on each immunoreactive 
fraction, Met-enk-like material eluted as two sharp peaks at a 
R v of, respectively, 13.25 and 23.4 min and Leu-enk-like mate- 
rial at a RT of, respectively, 14.5 rain and 25.4 min. The final 
step of purification was performed on an ODS C18 reverse- 
phase column which gave four homogeneous peaks, designated 
P1-P4, at Rv, respectively, of 19.87, 20.37 rain, 24.6 min and 
26.22 min. 
3.2. Character&ation of the enkephalin-like peptides 
A total of four immunoreactive p ptides, designated P1-P4, 
were isolated in this study. 
Given that peptides P3 and P4 co-eluted in reverse-phase 
HPLC with, respectively, Met-enk and Leu-enk, experiments 
were conducted in order to check that P3 and P4 corresponded 
effectively to these two pentapeptides. As Met-enk contained 
a methionine, the oxidized form of Met-enk [M(o)-enk], is more 
hydrophilic than Met-enk and thus elutes earlier than Met-enk. 
P1 P4 were oxidized. Separation of P1, P2, P3 and P4 on a 
Vydac column showed that P1 and P3 gave two peaks shifted 
to an earlier time (17.35 min vs. 19.87 min for P1 and 22.4 min 
vs. 24.6 for P3) whereas P2 and P4 did not shift. These results 
suggested the existence of a methionine amino acid residue only 
in Pl and P3. In order to confirm such a hypothesis, each 
purified peptide was subjected to automated Edman degrada- 
tion followed by ESMS. The amino acid sequences of P1-P4 
determined by automated Edman degradation are Phe-Met for 
P1, Phe-Leu for P2, Tyr-Gly-Gly-Phe-Met for P3 and Tyr-Gly- 
Gly-Phe-Leu for P4 (Table 2). The sequences obtained were 
Table 1 
Purification of enkephalins in the brain of the leech Theromyzon tessulatum 
Step Column material Elution conditions Yield 
(acetonitrile) (%) 
1 Solid phase extraction Sep-Pak C~8 cartridges 50% 100 
2 HPGPC Ultraspherogel, 7.5 × 300 nm 30% 83 
3 Reverse-phase HPLC Vydac C~8, 4.6 × 250 nm 0-15% (10 min) 75 
1545% (30 min) 
4 Reverse-phase HPLC Vydac C~8, 4.6 × 250 nm 0-15% (10 min) 70 
1545% (40 min) 
5 Final purification Ultrasphere C~8 , 2 × 250 nm 0-60% (60 min) 62 
Experimental details are indicated in section 2 
M. Salzet et al./FEBS Letters 357 (1995) 18~191 189 
1 
an b c d 
V • • • 
I 
I , - 
' #e,m'L 
Fig. 1. HPGPC elution profile of an acidic extract of 1000 brains from 
T. tessulatum. Arrowheads indicate the elution position of standards 
(a, hirudin (7 kDa); b, adrenocorticotropic hormone (4.5 kDa); c, 
angiotensin II (1.0 kDa); d, tryptophan (0.20 kDa)). The black bar 
indicates the zone immunoreactive to nkephalin antisera. The dotted 
lines indicate the isocratic gradient (30% acetonitrile). 
confirmed by mass spectrometry analyses. The molecular 
masses of P1-P4 measured by ESMS yielded a m/z of 
164.8 + 0.2 Da for P1,278.15 + 0.3 Da for P2, 573.4 + 0.33 Da 
for P3 and 555.5 + 0.6 Da for P4. These different m/z are in 
good agreement with the calculated mono-isotopic mass of FM 
(165.04 Da), FL (278.36 Da), YGGFM (573.2 Da) and 
YGGFL (555.2 Da). Moreover, co-injection in reverse-phase 
HPLC of either P3 and synthetic Met-enk or of P4 and syn- 
thetic Leu-enk indicated that in both cases a single peak was 
eluted. 
These results established the presence of a methionine- 
enkephalin (P3), leucine-enkephalin (P4) and two dipeptides 
FM (P1) and FL (P2) in the brain of the leech T. tessulatum. 
The amount of these peptide estimated at the final step of 
purification isca. 0.70 for P1, ca. 0.45 for P2, ca. 1.5 for P3 and 
ca 3.5 pmol/brain for P4 (Table 3). 
4. Discussion 
After reverse-phase HPLC purification, the sequence of the 
enkephalin-like p ptides was established by a combination of
automated Edman degradation, electrospray mass spectrome- 
try measurement, and co-elution experiments in reverse-phase 
HPLC with synthetic peptides. Our data show that Leu-enk 
and Met-enk from the leech T. tessulatum are structurally iden- 
tical to those of vertebrates. Similar results were previously 
obtained by Leung and Stefano [7] in the mollusc Mytilus edulis 
and by Luschen et al. [8] in the crustacean Carcinus maenas L. 
However, by the isolation of these enkephalins in leeches, we 
establish the existence of opioids in the oldest group of coelo- 
mate metazoans, the Annelida. We could postulate that 
enkephalins have a very ancient phylogenetic origin and are 
well conserved uring evolution. These results lead to two cen- 
tral questions: what was the ancestral opioid gene? What are 
the opioid precursors in leeches? 
4.1. Phylogeny of enkephalins in leeches 
In vertebrates, opioids are derived from three different large 
precursor molecules, i,e. the proenkephalin (Proenk), the 
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Fig. 2. Reverse-phase HPLC separation ofthe zone immunoreactive to 
the enkephalin antisera previously detected after separation ofan acidic 
extract of T. tessulatum brains in HPGPC. (A) The filled bars indicate 
the material immunoreactive to the anti-Met-enkephalin; (B) the filled 
bars indicate the material immunoreactive to the anti-Leu-enkephalin. 
Each zone containing the immunoreactive material was detected by 
ELISA. Values given for each assayed fraction correspond toaliquots 
of I/11. Arrows indicate the eluted position of synthetic Met-enkephalin 
(Met-enk) and synthetic Leu-enkephalin (Leu-enk). The acetonitrile/ 
water gradient isshown by a dashed line (see section 2for conditions). 
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Table 2 
Automated Edman degradation ofenkephalins (P1-P4) 
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Cycle no. Amino acid sequences 
PI P2 P3 P4 
PTH-AA Yield (pmol) PTH-AA Yield (pmol) PTH-AA Yield (pmol) PTH-AA Yield (pmol) 
1 F 43 F 30 Y 1556 Y 2683 
2 M 21 L 27 G 1763 G 3770 
3 G 1868 G 4144 
4 F 1811 F 2020 
5 M 985 L 1982 
prodynorphin (Prodyn) and the POMC [21]. Cleavage of these 
precursors gives, respectively, the enkephalins, the dynorphins 
and the endorphins [21]. The mammalian Proenk contains four 
copies of Met-enk, one of Leu-enk and two Met-enk extended 
(Met-enk-RF (YGGFMRF) and Met-enk-RGL (YGGFMR- 
GL)) [22]. Such an organisation has also been found with little 
variation in other vertebrates phyla (for a review see [23]). In 
invertebrates, the existence of an opioid precursor(s) is still 
unknown. Additionally, it is unknown whether invertebrates 
possess opioid peptides other than enkephalins [24]. 
In the leech T. tessulatum, immunocytochemical studies per- 
formed at the level of the brain revealed that Leu-enk and 
Met-enk are expressed in different neurons [14]. These results 
suggest: (i) a genic organisation different from that found in 
mammals, with the presence of two separated genes, one coding 
for the Met-enk and the other one for Leu-enk; or (ii) if we 
consider the hypothesis of the existence of an ancestral Proenk 
in invertebrates, these two pentapeptides could result from a 
post-translational processing mechanism where the Leu-enk is 
not liberated from cells expressing Met-enk and vice versa. 
The first hypothesis i sustained by results obtained in the 
agnata Ichthyomyzon castanaus and Petromyzon marinus [25]: 
the authors demonstrated Met-enk but not Leu-enk in pars 
intermedia. Theses results were interpreted by the authors as 
(i) the result of a unique post-translational processing mecha- 
nisms where the Leu-enk sequence is not liberated from the 
Proenk in any of these fish; or (ii) the Proenk is relatively simple 
and contains only Met-enk sequences but no copy of the Leu- 
enk sequence [25]. Furthermore data obtained in the anuran 
Xenopus laevis have revealed that a relatively simple organiza- 
tion of the Proenk provides the more likely explanation. In this 
Table 3 
Amounts of leucine-enkephalin or methionine-enkephalin im-
munoreactive material after Sep-Pak Cl8 prepurification a d of each 
identified enkephalin-like p ptides (P1-P4) isolated at the final step of 
purification 
Amount (pmol/brain) 
Prepurification step 
Leu-enk-like immunoreactivity 6.32 + 1.25 
Met-enk-like immunoreactivity 3.75 + 0.95 
Final purification step 
Peptide 
FM (P1) 0.69 _+ 0.36 
FL (P2) 0.45 +_ 0.28 
YGGFM (P3) 1.32 _+ 0.45 
YGGFL (P4) 3.49 + 0.55 
Values are expressed asa mean + S.D. (from four determinations). 
species, the Proenk gene was isolated [26] and the single copy 
of the Leu-enk sequence found to be replaced by a Met-enk 
sequence [26]. Moreover, Leu-enk as well as the Prodyn end- 
products (~-neo-endorphin and dynorphin A (1-8)) have been 
detected in X. laevis brain [27]. However, dynorphin (1 17) and 
dynorphin B were not immunologically detected [27]. These 
data are in favor of the conversion of some Xenopus Prodyn 
products into Leu-enk and establish the existence of two differ- 
ent genes coding for enkephalins in amphibians [28]. 
In invertebrates, detection by immunocytochemistry of the 
Prodyn end-products left no doubt hat Proenk is not the only 
source of Leu-enk in neural tissue: Leu-enk could also derive 
from a Prodyn [29]. Results obtained in the crustacean Carcinus 
maenas L. are in line with this hypothesis. The molar ratio of 
Leu-enk and Met-enk in crustacea is 3 : 1 [8]. This result proves, 
in contrast o what is found in mammals, that Leu-enk is the 
predominant enkephalin peptide in crustacea. ELISA titrations 
performed in T. tessulatum confirm this result. In leeches, 
enkephalins are present at a ratio of Leu-enk to Met-enk of 2: 1. 
This value is strengthened by immunocytochemical studies re- 
vealing a much higher number of cells immunoreactive to 
a-Leu-enk than to a-Met-enk [14]. The whole of these results 
are reinforced by the specificity of the antisera used [18]. 
These data strongly suggest that, in the leech, Met-enk and 
Leu-enk are coded by two different genes. The existence of a 
Prodyn-related precursor is strongly suggested by immunocy- 
tochemical results [14]. Cells immunoreactive to antibodies spe- 
cific to vertebrate Prodyn, i.e. anti-dynorphin a d anti-~-neo- 
endorphin, were detected in T. tessulatum brain [14]. Moreover, 
recently apeptide present in vertebrates on an opioid precursor 
of ca. 60 kDa, the pro-opiomelanocortin (POMC), has been 
isolated from T. tessulatum brains. This peptide is related to 
y-MSH: it has ca. 80% sequence homology to vertebrate 
y-MSH [30]. However, in leeches no POMC was detected. 
Western blot analyses performed in T. tessulatum have revealed 
the existence of a multipeptidic precursor of ca. 19 kDa. This 
protein possesses at least three epitopes recognized by two 
different polyclonal antisera (an anti-~,-MSH and an anti- 
angiotensin II) and by a monoclonal ntibody (Tt159) specific 
for epitopes contained in T. tessulatum supraesophageal g n- 
glia extracts [31]. 
These observations in leech allow us to postulate that 
enkephalins are the most ancient class of opioids and to pro- 
pose a form of the Proenk gene as the ancestral opioid gene. 
This ancestral opioid gene would have been subjected to a first 
duplication, which would have occurred before or in annelids, 
to give rise to a Proenk and a Prodyn gene. Nevertheless, to
M. Salzet et al./FEBS Letters 357 (1995) 187-191 191 
establish the truth of these suggestions in invertebrates, the 
isolation of peptides related to the Prodyn end-products and a 
molecular study of opioid precursors in leeches have to be 
undertaken. 
4.2. Enkephalin peptidases 
In parallel with the purification of these two pentapeptides, 
two dipeptides FM and FL were isolated. The presence of the 
dipeptides FL and FM could be due to proteolytic action of 
peptidases. Recently, Leung et al. [32] demonstrated Met-enk 
peptidases in the hemolymph of the mollusc M. edulis. As 
suggested by the authors, the presence of the dipeptide FM 
could result from the specific action of an angiotensin-convert- 
ing enzyme (ACE) in M. edulis hemolymph. Such a hypothesis 
could be sustained in the case of the leech T. tessulatum. Indeed, 
an angiotensin II-like molecule close to vertebrate angiotensin 
II has been isolated in the brain of leech [31]. However, the 
existence of a neutral endopeptidase or a carboxypeptidase 
which cleaves Met-enk and/or Leu-enk, can not be excluded. 
These results suggest he presence of enkephalin peptidases in 
leech. The validity of these suggestions requires further experi- 
mental testing. 
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